Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.79 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.60 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | TNF | P01375 | 1/20 | 0.54 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.54 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.54 |
| ▸ | RBBP9 | O75884 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.52 |
| ▸ | MITF | O75030 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | XDH | P47989 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10779103 | 0.88 | SMN1; SMN2 (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL12328529 | 0.88 | SMN1; SMN2 (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL92080 | 0.86 | MAPT (0.78) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL1357956 | 0.86 | MAPT (0.78) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL194739 | 0.84 | SMN1; SMN2 (0.59) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL194740 | 0.84 | SMN1; SMN2 (0.59) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL20278523 | 0.82 | KMT2A (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL195165 | 0.82 | KMT2A (0.62) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL92110 | 0.82 | SMN1; SMN2 (0.57) | SMN1; SMN2MAPTCDK5CDK5R1PKM | |
| SCHEMBL14667500 | 0.82 | MAPT (0.59) | SMN1; SMN2MAPTCDK5CDK5R1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0892846-B1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AG (DE) | 2002-10-23 | — | — | EP | claimed |
| US-6130198-A | Bleaching efficiency boosters for bleach and textile detergent compositions | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-10 | — | — | US | claimed |
| EP-0892846-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-27 | — | — | EP | claimed |
| WO-1997035950-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | claimed |
| EP-4658663-A2 | PRODRUGS OF 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | Merck Sharp & Dohme LLC (US) | 2025-12-10 | — | — | EP | disclosed |
| CN-116601246-B | Ink set, laminate, and method for producing laminate | 富士胶片株式会社 | 2024-09-17 | — | — | CN | disclosed |
| US-20240287124-A1 | PRODRUGS OF 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2024-08-29 | — | — | US | disclosed |
| WO-2024163262-A2 | PRODRUGS OF 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2024-08-08 | — | — | WO | disclosed |
| CN-116601246-A | Ink set, laminate, and method for producing laminate | 富士胶片株式会社 | 2023-08-15 | — | — | CN | disclosed |
| EP-1524313-B2 | MACHINE DISHWASHING COMPOSITION WITH IMPROVED RINSING PROPERTIES | DALLI WERKE GMBH & CO KG (DE) | 2021-12-15 | — | — | EP | disclosed |
| EP-2963495-B1 | INFRARED-SENSITIVE CHROMOGENIC COMPOSITION, INFRARED-CURABLE CHROMOGENIC COMPOSITION, LITHOGRAPHIC PRINTING PLATE PRECURSOR, AND PLATE FORMATION METHOD | FUJIFILM CORP (JP) | 2019-06-05 | — | — | EP | disclosed |
| EP-2818522-B1 | CHROMOGENIC COMPOSITION, CHROMOGENIC CURABLE COMPOSITION, LITHOGRAPHIC PRINTING PLATE PRECURSOR, PLATEMAKING METHOD, AND CHROMOGENIC COMPOUND | FUJIFILM CORP (JP) | 2018-11-21 | — | — | EP | disclosed |
| EP-0964912-A1 | DETERGENT AND CLEANING AGENT FORMULATION WITH A BLEACHING SYSTEM AND A MIXTURE OF AMINES AND COMPLEXING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1999-12-22 | — | — | EP | disclosed |
| EP-0958345-A2 | ACTIVATORS FOR PER COMPOUNDS | ORACLE CORPORATION (US) | 1999-11-24 | — | — | EP | disclosed |
| EP-0941299-A2 | TEXTILE DETERGENT FORMULATION ON THE BASIS OF QUATERNIZED GLYCINE NITRILES, BLEACHING AGENTS, NONIONIC AND/OR ANIONIC TENSIDES AND CALCIUM ION AND/OR MAGNESIUM ION SEQUESTERING COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-15 | — | — | EP | disclosed |
| EP-0892846-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-27 | — | — | EP | disclosed |
| WO-1998033878-A2 | ACTIVATORS FOR PER COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998032830-A1 | DETERGENT AND CLEANING AGENT FORMULATION WITH A BLEACHING SYSTEM AND A MIXTURE OF AMINES AND COMPLEXING AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-30 | — | — | WO | disclosed |
| WO-1998023718-A2 | TEXTILE DETERGENT FORMULATION ON THE BASIS OF QUATERNIZED GLYCINE NITRILES, BLEACHING AGENTS, NONIONIC AND/OR ANIONIC TENSIDES AND CALCIUM ION AND/OR MAGNESIUM ION SEQUESTERING COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-04 | — | — | WO | disclosed |
| WO-1997035950-A1 | BLEACHING POWER ENHANCERS FOR BLEACHES AND TEXTILE WASHING COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287124-A1 | PRODRUGS OF 4'-SUBSTITUTED NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | DNTT, NAPRT, NAMPT | SMN1; SMN2 2653/4885MAPT 1204/4885CDK5 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.